A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC)
Saba, Nabil F., Ekpenyong, Asari, McCook-Veal, Ashley, Patel, Mihir, Schmitt, Nicole Cherie, Stokes, William A., Bates, James Edward, Rudra, Soumon, Abousaud, Marin Ibrahim, Muzaffar, Jameel, Kirtane, Kedar, Teng, Yong, Steuer, Conor Ernst, Shin, Dong Moon, Liu, Yuan, Chung, Christine H.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase II trial of radiotherapy (RT) with concurrent cisplatin (C) plus panitumumab (pmAb) for patients (pts) with high-risk, resected head and neck cancer (HNC)
Ferris, Robert L., Schmitt, Nicole Cherie, Heron, Dwight Earl, Johnson, Jonas Talmadge, Kim, Seungwon, Duvvuri, Umamaheswar, Clump, David Andrew, Grandis, Jennifer, Bauman, Julie E., Gooding, William E., Argiris, Athanassios
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article